Calprotectin: A novel noninvasive marker for intestinal allograft monitoring

Annals of Surgery

Volumn 246, Issue 2, 2007, Pages 311-315

  Sudan, Debra ^a,c   Vargas, Luciano ^a   Sun, Yimin ^a   Bok, Lisette ^b   Dijkstra, Gerard ^b   Langnas, Alan ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPROTECTIN;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BIOPSY; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; ENTERITIS; FECES ANALYSIS; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEOSTOMY; INTESTINE GRAFT; LABORATORY DIAGNOSIS; MONITORING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCREENING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INFANT; INTESTINE, SMALL; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547591860     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3180f61af4     Document Type: Article

References (32)

1. Kaufman SS, Atkinson JB, Bianchi A, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant. 2001;5:80-87.
2. Sudan D. Small bowel transplantation: current status and new developments in allograft monitoring. Curr Opin Organ Transplant. 2005;10:124-127.
3. Sudan DL, Chinnakotla S, Horslen S, et al. Basiliximab decreases the incidence of acute rejection after intestinal transplantation. Transplant Proc. 2002;34:940-941.
4. Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation. 2003;76:636-640.
5. Gaynor JJ, Kato T, Selvaggi G, et al. The importance of analyzing graft and patient survival by cause of failure: an example using pediatric small intestine transplant data. Transplantation. 2006;81:1133-1140.
6. Ishii T, Mazariegos GV, Bueno J, Ohwada S, Reyes J. Exfoliative rejection after intestinal transplantation in children. Pediatr Transplant. 2003;7:185-191.
7. Sudan DL, Kaufman S, Horslen S, Fox I, Shaw BW Jr, Langnas A. Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients. Transplant Proc. 2000;32:1199.
8. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005;241:607-613.
9. Manez R, Kusne S, Green M, et al. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation. 1995;59:1010-1014.
10. Kakugawa Y, Kami M, Kozu T, et al. Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation. Gut. 2006;55:895-896.
11. Sudan DL, Kaufman SS, Shaw BW Jr, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol. 2000;95:1506-1515.
12. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc. 2004;36:335-337.
13. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med. 2002;137:132-141.
14. Sigurdsson L, Reyes J, Putnam PE, et al. Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol. 1998;93:207-211.
15. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ. A schema for histologic grading of small intestine allograft acute rejection. Transplantation. 2003;75:1241-1248.
16. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:50-54.
17. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119:15-22.
18. Poullis A, Foster R, Northfield TC, Mendall MA. Review article: faecal markers in the assessment of activity in inflammatory bowel disease. Aliment Pharmacol Ther. 2002;16:675-681.
19. Fagerhol MK. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet. 2000;356:1783-1784.
20. Striz I, Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245-253.
21. Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull. 2003;26:753-760.
22. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem. 1997;272:9496-9502.
23. Boussac M, Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis. 2000;21:665-672.
24. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol. 2001;70:130-134.
25. Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A. Faecal calprotectin: a new marker for Crohn's disease? Ann Clin Biochem. 2004;41:230-232.
26. Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med. 2001;344:947-954.
27. Gondolesi GE, Kaufman SS, Sansaricq C, et al. Defining normal plasma citrulline in intestinal transplant recipients. Am J Transplant. 2004;4:414-418.
28. Pappas PA, GT A, Gaynor JJ, et al. An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplant. Am J Transplant. 2004;4:1124-1132.
29. Burkhardt K, Bosnecker A, Hillebrand G, et al. MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation. Transplant Proc. 1995;27:890-891.
30. Goebeler M, Roth J, Burwinkel F, Vollmer E, Bocker W, Sorg C. Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation. 1994;58:355-361.
31. Frachon I, Fattal-German M, Magnan A, et al. Emergence of inflammatory alveolar macrophages during rejection or infection after lung transplantation. Transplantation. 1994;57:1621-1628.
32. Ikemoto M, Tanaka T, Takai Y, Murayama H, Tanaka K, Fujita M. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin Chem. 2003;49:594-600.